A recent study has revealed how socioeconomic disadvantage and genetic predisposition combine to influence obesity risk from early childhood through adolescence.

Recognising that men are less likely to participate in traditional weight-loss programmes, a new study published in The Lancet highlighted an innovative approach to change that - Hockey Fans in Training (Hockey FIT).

At the recent Obesity Week 2024 conference in America, new research revealed that people taking anti-obesity medications (AOMs), including popular GLP-1 drugs, appear to decrease their alcohol consumption.

Registrations are now open for a free webinar exploring how bias may influence the care and well-being of people living with obesity.

The Scottish Government and NHS Scotland have released a landmark consensus statement aimed at standardising the use of injectable weight management drugs across the country.

In a groundbreaking study, researchers have identified a critical link between the liver and brain that helps regulate our daily eating patterns, offering a promising new approach for managing obesity.

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning to healthcare professionals, urging vigilance for signs of misuse involving popular obesity injections like Wegovy. The advisory follows reports of individuals using these weight-loss drugs without medical need, leading to severe health complications.

Tirzepatide is effective for long-term weight loss and diabetes prevention in people with obesity and prediabetes, a trial reported at a meeting of the Obesity Society has demonstrated. 

Researchers from Nanyang Technological University Singapore (NTU Singapore) and Hong Kong University (HKU) have found that electro-acupuncture, a modern take on traditional Chinese medicine, could play a significant role in managing obesity. Their findings suggest that this ancient technique may impact a protein called osteoprotegerin, a known influencer of fat cell growth.

A recent study published in the New England Journal of Medicine has revealed promising results for individuals living with obesity and knee osteoarthritis.

A recent study, published in Obesity, has found that individuals using antidepressants, specifically selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs), may experience significant changes in fat distribution and muscle composition, potentially heightening their risk of developing cardiovascular disease and type 2 diabetes.

The Obesity & Weight Management Alliance is excited to announce a call for poster submissions for its highly anticipated 2025 conference, taking place on March 7 at the Thistle London Marble Arch.

The House of Lords Food, Diet and Obesity Committee has issued a powerful call to action, highlighting the dire state of the UK’s food system and the escalating public health crisis caused by obesity. Appointed in January 2024 and re-established in July following the State Opening of Parliament, the Committee has presented a comprehensive report detailing a plan to overhaul the nation's approach to diet and health.

A new study has found a significant connection between the consumption of ultra-processed foods and the rise of metabolic disorders, including liver disease and insulin resistance, in children and adolescents living with obesity. The findings highlight the urgent need for improved dietary guidelines and public health measures to address this growing concern.

China’s National Health Commission (NHC) has introduced its first set of national guidelines to standardise the diagnosis and treatment of obesity, as the country grapples with a growing public health crisis.

George Yancopoulos, co-founder and chief scientific officer of Regeneron, has raised concerns about the long-term impact of popular weight-loss drugs, warning they could cause "more harm than good" due to rapid muscle loss.

The Obesity Health Alliance has launched its ambitious 10-year strategy, "Turning the Tide: A 10-Year Healthy Weight Strategy," aimed at reversing the rising levels of obesity across the UK.

A new study led by the National Institute on Aging (NIA) suggests that older adults living with obesity and metabolic issues can boost their brain health by following a healthy diet.

New results from the SELECT trial show that semaglutide 2.4 mg significantly reduces all-cause mortality in patients with obesity and cardiovascular disease, including deaths related to COVID-19.

Weight-loss medications may be a powerful tool in tackling obesity, but they are not the ultimate solution to the crisis, according to Professor Stephen Powis, NHS England's Medical Director.